RB1 and cancer: Their activity is primarily regulated by interactions with the retinoblastoma tumour suppressor protein (pRb); the pRb–E2F pathway is central in regulating cell cycle progression and its functional deregulation is of primary importance in proliferative diseases such as cancer [173].